{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:23:13Z","timestamp":1791235393113,"version":"4.1.0"},"reference-count":25,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[1999,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>A competitive quantitative PCR (Q-PCR) assay combined with simple silica-based DNA extraction was developed for monitoring of Epstein-Barr virus (EBV) DNA load in unfractionated peripheral blood. The Q-PCR is based on competitive coamplification of a highly conserved 213-bp region of the EBNA-1 open reading frame with an internal standard (IS), added in a known concentration. The IS has the same amplicon length and base composition as the wild-type (WT) EBNA-1 amplicon but differs in 23 internally randomized bases. Competitive coamplification yields two PCR products that are quantified by enzyme immunoassay or by electrochemiluminescence detection, with probes specific for the 23 differing internal nucleotides. The Q-PCR has a sensitivity of 10 copies of either WT or IS plasmid DNA. The Q-PCR was validated by quantification of known amounts of plasmid containing the WT EBNA-1 target. Furthermore, we determined EBV genome copy numbers in different cell lines. For EBV quantification in clinical samples, DNA was isolated from lysed whole blood by silica-affinity purification. Forty-six percent of healthy donor peripheral blood samples were positive by Q-PCR. In most of these samples, viral load was less than 2,000 EBV copies\/ml of blood. In peripheral blood samples from two AIDS-related non-Hodgkin\u2019s lymphoma patients, elevated EBV loads (up to 120,000 copies\/ml) were observed, which decreased upon therapy. In Burkitt\u2019s lymphoma patients, up to 4,592,000 EBV genome copies\/ml of blood were detected. In conclusion, the EBNA-1-based Q-PCR assay provides a reproducible, accurate, and easy method for studying the relationship between EBV load and clinical parameters.<\/jats:p>","DOI":"10.1128\/jcm.37.9.2852-2857.1999","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T12:48:59Z","timestamp":1577796539000},"page":"2852-2857","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":101,"title":["Monitoring of Epstein-Barr Virus DNA Load in Peripheral Blood by Quantitative Competitive PCR"],"prefix":"10.1128","volume":"37","author":[{"given":"Servi J. C.","family":"Stevens","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Pathology, University Hospital Vrije Universiteit,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel B. H. J.","family":"Vervoort","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Pathology, University Hospital Vrije Universiteit,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan J. C.","family":"van den Brule","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Pathology, University Hospital Vrije Universiteit,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter L.","family":"Meenhorst","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Slotervaart Hospital,2 Amsterdam, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J. L. M.","family":"Meijer","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Pathology, University Hospital Vrije Universiteit,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap M.","family":"Middeldorp","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Pathology, University Hospital Vrije Universiteit,1 and"},{"name":"<!--label omitted: 3-->Organon Teknika, Boxtel,3 The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.61.5.1743-1746.1987"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/43.10.1843"},{"key":"e_1_3_2_4_2","first-page":"177","article-title":"Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt\u2019s lymphomas","volume":"13","author":"Bhatia K.","year":"1996","unstructured":"Bhatia K. Raj A. Guitierrez M. I. Judde J. G. Spangler G. Venkatesh H. Magrath I. T. Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt\u2019s lymphomas.Oncogene131996177181","journal-title":"Oncogene"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.28.3.495-503.1990"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199904)57:4<383::AID-JMV10>3.0.CO;2-3"},{"key":"e_1_3_2_7_2","unstructured":"International Agency for Research on Cancer\nIARC monographs on the evaluation of carcinogenic risks to humans\n70. Epstein-Barr virus and Kaposi sarcoma herpesvirus\/human herpesvirus 8\n1997\nInternational Agency for Research on Cancer\nLyon France"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(199607)49:3<223::AID-JMV11>3.0.CO;2-D"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711700206"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199509270-00005"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119315"},{"key":"e_1_3_2_12_2","unstructured":"Kieff\nE.\nEpstein-Barr virus and its replication\nFields virology.\nFields\nB. N.\nKnipe\nD. M.\nHowley\nP. M.\n1996\n2343\n2396\nLippincott-Raven Publishers\nPhiladelphia Pa"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/339237a0"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890460115"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(88)90530-2"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.10.3654"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/bmme.1997.2571"},{"key":"e_1_3_2_18_2","first-page":"665","article-title":"Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma","volume":"4","author":"Mutirangura A.","year":"1998","unstructured":"Mutirangura A. Pornthanakasem W. Theamboonlers A. Sriuranpong V. Lertsanguansinchi P. Yenrudi S. Voravud N. Supiyaphun P. Poovorawan Y. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.Clin. Cancer Res.41998665669","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.3.972.972"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08904.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.6.1612-1615.1997"},{"key":"e_1_3_2_22_2","first-page":"1545","article-title":"Alterations in the structure of the EBV nuclear antigen, EBNA-1, in epithelial tumours","volume":"10","author":"Snudden D. K.","year":"1995","unstructured":"Snudden D. K. Smith P. R. Lai D. Ng M. Griffin B. E. Alterations in the structure of the EBV nuclear antigen, EBNA-1, in epithelial tumours.Oncogene10199515451552","journal-title":"Oncogene"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.28.12.2739-2743.1990"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.11.2826-2829.1992"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1995.1183"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.2144\/96212rv01"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.37.9.2852-2857.1999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.37.9.2852-2857.1999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T19:10:57Z","timestamp":1646421057000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.37.9.2852-2857.1999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["10.1128\/JCM.37.9.2852-2857.1999"],"URL":"https:\/\/doi.org\/10.1128\/jcm.37.9.2852-2857.1999","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,9]]},"assertion":[{"value":"1999-04-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-06-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}